Search Menu
Photonics Media Photonics Marketplace Photonics Spectra BioPhotonics Vision Spectra Photonics Showcase Photonics ProdSpec Photonics Handbook

Evotec, Active Biotech Ink Screening Pact

Facebook Twitter LinkedIn Email
HAMBURG, Germany, March 22, 2010 – Evotec AG announced it has entered into a collaboration with Active Biotech AB to identify small-molecule modulators of a priority biological target, selected by the latter company, involved in immune disorders and cancer.

The former company, a novel small-molecule drugs discovery and development company, will use its technologies in assay development, high-throughput screening and surface plasmon resonance screening for the identification and validation of novel hits. It will screen its Lead Discovery Library, a small-molecule collection, to maximize the probability of finding medicinal chemistry starting points.

Active Biotech, of Lund, Sweden, is an autoimmune and inflammatory diseases and cancer biotechnology company.

For more information, visit:
Mar 2010
See acousto-optic modulator; electro-optic modulator.
Calculated quantity of the entire longitudinal wave of a solid substance's electron gas.
Active BiotechautoimmuneBasic Sciencebiological targetBiophotonicsbiotechnologyBusinesscancercollaborationdrug discoveryEuropeEvotecEvotec AGGermanyhigh-throughput screeningimmune disorderinflammatoryLead Discovery Librarymedicinal chemistrymodulatormoleculeplasmonscreeningsmall molecule drugssurface plasmon resonanceSweden

back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2023 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA, [email protected]

Photonics Media, Laurin Publishing
x We deliver – right to your inbox. Subscribe FREE to our newsletters.
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.